Browse by Clinical Topic:

Featured CME/CE Content:
neuroscienceCME Editors' Picks:

The Management of Comorbid Conditions in Patients with Rheumatoid Arthritis

Premiere Date: Monday, August 15, 2016

This activity offers CE credit for:

  1. Physicians (CME)
  2. Nurses (CNE)
  3. Pharmacists (ACPE)
  4. Other

All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™

Credit Expiration Date:
Tuesday, August 15, 2017
Note: Credit Is No Longer Available


Leonard H. Calabrese, DOLeonard H. Calabrese, DO 
Professor of Medicine
Vice Chair, Department of Rheumatic & Immunologic Disease
Cleveland Clinic Lerner College of Medicine
of Case Western Reserve University
R.J. Fasenmyer Chair of Clinical Immunology
Cleveland Clinic Foundation
Cleveland, OH

M. Elaine Husni, MD, MPHM. Elaine Husni, MD, MPH 
Vice Chair and Director
Arthritis & Musculoskeletal Center
Department of Rheumatic and Immunologic Diseases
Cleveland Clinic
Assistant Professor
Cleveland Clinic Lerner College of Medicine
of Case Western Reserve University
Cleveland, OH

Statement of Need

Strong evidence demonstrates that patients with rheumatoid arthritis (RA) are at a high risk for developing several comorbid disorders; these conditions may have atypical features, and thus may be difficult to diagnose. In one study, an estimated 80% of patients with RA have one or more comorbidities.1

If not managed effectively, comorbidities can have wide ranging impacts on people with RA – worsening their levels of physical disability, increasing support needs, reducing their ability to work, and increasing risk of mortality. Because many of these coexistent conditions respond to preventive or therapeutic measures, comorbidity needs to be detected and managed to reduce impact on patients with RA.1

In this CME Outfitters decision-tree medical simulation participants will navigate the clinical challenges presented by a patient with RA. Along the way, expert faculty will provide guidance, insights, and evidence for the positive and negative consequences of their decisions. This actionable, evidence-based simulation and improve clinician confidence in their ability to recognize and assess comorbidities, improve coordination of care among health care providers, and develop personalized treatment plans for managing comorbid conditions in patients with RA.

1. National Rheumatoid Arthritis Society [NRAS]. The impact of rheumatoid arthritis comorbidities. Published December 2012. Accessed August 15, 2016.

Learning Objectives

At the end of this CE activity, participants should be able to:

  • Recognize and routinely assess for comorbid conditions in patients with RA.
  • Devise a plan to coordinate care with other health care providers to appropriately manage comorbidities in patients with RA.
  • Engage patients in discussions about comorbidities associated with RA on each visit.

Financial Support

Supported by an educational grant from Pfizer Inc.

Target Audience

Rheumatologists, internists, primary care physicians, physician assistants, nurse practitioners, nurses, pharmacists, and other health care providers that manage patients with rheumatoid arthritis

Credit Information

CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CME Outfitters, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CNE Credit (Nurses):
Provider approved by the California Board of Registered Nursing, Provider Number CEP 15510, for 1.0 contact hours.

Note to Nurse Practitioners and Clinical Nurse Specialists: the content of this activity pertains to pharmacology. Earn up to 1.0 contact hours of pharmacotherapeutic contact hours.

CPE Credit (Pharmacists):
ACPE CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.0 contact hours (0.1 CEUs)
Universal Activity Number: 0376-0000-16-021-H01-P
Activity Type: application-based

Successful completion of this CE activity includes participating in the activity, reviewing the course materials, and following the appropriate set of instructions below within 30 days of completion of the activity:

To complete your activity evaluation and post-test online, and print your certificate or statement of credit immediately (75% pass rate required), please visit (requires free account activation).

There is no fee for participation in this activity. The estimated time for completion is 60 minutes.

Questions? Please call 877.CME.PROS.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CME/CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CME/CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Calabrese has disclosed that he serves on the speakers bureau for AbbVie Inc.; Bristol-Myers Squibb Company; Crescendo Bioscience; Genentech Inc.; and Janssen Pharmaceuticals, Inc. He serves as a consultant to GlaxoSmithKline; Pfizer Inc.; and sanofi-aventis U.S. LLC.

Dr. Husni has disclosed that she serves as a consultant to AbbVie Inc.; Amgen inc.; Bristol-Myers Squibb Company; and Janssen Pharmaceuticals, Inc.

Jeffrey Helfand, DO, MS (peer reviewer) has no disclosures to report.

Kimberley Murray, RN, MS (peer reviewer) has no disclosures to report.

Frances Daniel, MPH (planning committee) has no disclosures to report.

Karen Roy, MSc., CHCP (planning committee) has disclosed that she serves as a consultant for Genentech Inc.; MedImmune; Takeda Pharmaceuticals U.S.A., Inc.; Teva Pharmaceuticals; and Upsher-Smith Laboratories, Inc..

Sharon Tordoff, CHCP (planning committee) has no disclosures to report.

Disclosures have been obtained from CME Outfitters staff: No disclosures to report.

Unlabeled Use Disclosure

Faculty of this CME/CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

CME Outfitters, LLC, the faculty, and Pfizer Inc. do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.

Questions about this activity? Call us at 877.CME.PROS (877.263.7767).


Home      |      Register/Log In      |      Activities      |      Communities of Practice      |      About      |      Download